Name | Interests | Department | |
---|---|---|---|
Madolene Aliparo | Pediatric Asthma Pediatric Tuberculosis | Department of Pediatrics | |
David Alland | Infectious Disease; Tuberculosis; drug resistance; biodefense;PCR diagnostics; | Department of Medicine | |
Padmapriya Banada | My overall research interest is in the development of integrative systems for sensitive, specific and rapid detection of bacteria, including Mycobacterium tuberculosis, fungi and viruses directly from the patient samples. | Department of Medicine | |
Nancy Connell | antibacterial drug discovery; predatory bacteria; novel antimicrobial agents; infectious disease immunology; mycobacterium tuberculosis; Select Agents; pathogen-macrophage interactions ; pathogenic mechanisms; biodefense; biological arms control; responsible conduct of research; active learning methodologies | Department of Medicine | |
Amy Davidow | Tuberculosis epidemiology, respiratory and infectious disease epidemiology longitudinal data analysis and biostatistics | Department of Preventive Medicine & Community Health | |
Thomas Dick | Research interests Disease area: Tuberculosis (TB), Non-Tuberculous Mycobacterial (NTM) lung disease. Topics: Antibacterial drug discovery, antimicrobial resistance. | Department of Medicine | |
Karl Drlica | Antibiotic action and resistance with a focus on M. tuberculosis and other human bacterial pathogens | Public Health Research Institute | |
Eugenie Dubnau | M. tuberculosis | Public Health Research Institute | |
Jerrold Ellner | Immunology;Infectious disease; innate immunity; tuberculosis and HIV infection | Department of Medicine | |
Patricia Fontan | Mycobacterium tuberculosis, bacterial pathogenesis | Public Health Research Institute | |
Maria Gennaro | Immunology; tuberculosis; Th1 immunity; B-cell and T-cell epitopes; tuberculosis immunology in children; infectious disease | Public Health Research Institute | |
Gilla Kaplan | Immunology and pathogenesis of tuberculosis and leprosy | Public Health Research Institute | |
Soyeon Kim | My research interests are aimed at mitigating the public health impact of the HIV/AIDS and the resulting resurgent tuberculosis (TB) epidemics. I have participated in research to evaluate methods of prevention of mother-to-child transmission of HIV, co-infections with HIV, prevention and treatment of TB, and TB diagnostics. Much of my research in has been conducted in developing countries, including Thailand, Botswana, and South Africa. Working overseas has also spurred my interest in research capacity building in resource limited countries where infectious diseases are more prevalent. | Department of Preventive Medicine & Community Health | |
Barry Kreiswirth | Infectious Disease;genotyping and evolutionary studies on Mycobacterium tuberculosis; Staphylococcus aureus | Public Health Research Institute | |
Marian Passannante | Impact of social factors on disease outcomes, questionnaire design and survey research, Epidemiology of tuberculosis, Injury epidemiology | Department of Preventive Medicine & Community Health | |
Richard Pine | Immunology; tuberculosis; type I/II interferons; host immunity to TB; interferon regulatory factor | Department of Medicine | |
Abraham Pinter | With the inability of available HIV-1 vaccines to achieve protection, there is a clear need for the identification of novel vaccine targets and approaches. A key focus of the work of Dr. Pinter's lab is understanding the basis for the inability of the immune system to control HIV, and identification of new targets and vaccine approaches that may be able to overcome these limitations. The role of conformational masking towards neutralization resistance is being analyzed in detail, with a focus on specific determinants that contribute to masking and identification of mutations that can r | Public Health Research Institute | |
Gloria Rodriguez | The main focus of the studies in my laboratory is the role of metal homeostasis in host-pathogen interactions. I am particularly interested in the effects of metal ion restriction resulting from nutritional immunity on the pathogenesis of M. tuberculosis (Mtb). My early training in bacteriology, cell biology and immunology, combined with over 25 years in the mycobacterial field, has given me the right foundation to study the biology of the tuberculous bacillus and the complex interplay between Mtb and its host. My group has significantly contributed to the current understanding of th | Public Health Research Institute | |
Hassan Safi | The long term of my research is to develop new vaccine against tuberculosis. I am using genetic tools as well as exposure to different chemicals as my model to create attenuated strains with strong immunogenic response and, therefore, efficient protection against tuberculosis. A ONE VACCINE with protection against all the strain types is the key for tuberculosis eradication. | Department of Medicine | |
Padmini Salgame | Immunology; Th1 immunity; tuberculosis; interleukin-12; T cell polarization; dendritic cells; Pathogenic Mechanisms; Infectious Disease | Department of Medicine | |
Issar Smith | tuberculosis, virulence, microbiology, public health; infectious disease;genetics of Mycobacterium tuberculosis virulence; genes controlled by the regulatory proteins essential for M. tuberculosis virulence;to develop new strategies for the diagnosis and treatment of tuberculosis | Public Health Research Institute | |
Vishwanath Venketaraman | Immunology; innate immunity; tuberculosis; glutathione regulatory pathways | Department of Medicine |
© 2018, Rutgers, The State University of New Jersey. All rights reserved.